
    
      Two doses of TPI ASM8 will be compared to placebo and look at the effect on asthmatic
      responses after an allergen challenge during a 3-way cross over design. Sputum inflammation ,
      mRNA gene expression on target receptors, ECP , biomarkers of mast cells activation et PK
      profile will be studied.
    
  